INVO Fertility Announces a 1:4 Reverse Stock Split Effective Pre-Market Opening on October 30, 2026
INVO Fertility, Inc. (IVF) filed an SEC Form 8-K — Other Events. Exhibit 99.1 INVO Fertility Announces a 1:4 Reverse Stock Split Effective Pre-Market Opening on October 30, 2026 SARASOTA, Fla., October 27, 2026 (GLOBE NEWSWIRE) – INVO Fertility, Inc. (“INVO”) (NASDAQ: IVF), a healthcare company focused on the establishment, acquisition and ope
How this was made
The 30-second read
Why it matters
The split will adjust the share structure, possibly improving liquidity and price perception, but does not change fundamentals.
Market read
Primary relevance is to IVF shareholders; limited spillover to the sector.
What to watch
Potential cash payout for fractional shares could attract small investors seeking immediate cash.
Background
INVO Fertility (NASDAQ: IVF) filed an 8‑K announcing a reverse split, a standard corporate action to boost share price perception.
Ticker impact
Company announced a 1-for-4 reverse stock split effective pre‑market on Oct 30 2026, changing share count and CUSIP.
possible modest upside as the split consolidates shares, but limited by low liquidity.
Reverse splits often trigger short‑term buying interest and a tighter price range; the effect is modest for a small‑cap biotech.
Market effects
Minimal impact on the broader fertility‑services sector; peers unlikely to be affected.
Limited to U.S. Nasdaq micro‑cap segment.
Low; no cross‑border implications.
Counterpoint
Some investors may view the split as a red flag and short the stock, expecting post‑split weakness.
Key entities
- companyINVO Fertility, Inc.
Nasdaq‑listed fertility services provider.
